Additional file 1 of A new histone deacetylase inhibitor remodels the tumor microenvironment by deletion of polymorphonuclear myeloid-derived suppressor cells and sensitizes prostate cancer to immunotherapy

Additional file 1: Table S1. Animals are grouped according to a random number provided by the supplier. Table S2. Baseline demographic and clinical characteristics of anti-PD1 treatment patients. Table S3. Primers for quantitative RT-PCR.

附加文件1：表S1。实验动物依据供应商提供的随机编号完成分组。表S2：抗PD-1（anti-PD1）治疗患者的基线人口统计学与临床特征。表S3：定量逆转录聚合酶链反应（quantitative RT-PCR）引物。